PODD News and Press, Insulet Corporation From 02/20/25

2025-02-20 23:37:39 ET More on Insulet Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript Insulet Non-GAAP EPS of $1.15 beats by $0.13, revenue of $597.5M beats by $15.48M v Seeking Alpha’s Quant Rating on Insulet Historical earnings d...

2025-02-20 23:37:03 ET Insulet Corporation (PODD) Q4 2024 Earnings Conference Call February 20, 2025 16:30 ET Company Participants June Lazaroff - Senior Director of Investor Relations Jim Hollingshead - President & Chief Executive Officer Ana Chadwick - Exec...

2025-02-20 16:43:29 ET More on Insulet v Investors seeking alpha should focus on 3 industries: Goldman Sachs Seeking Alpha’s Quant Rating on Insulet Historical earnings data for Insulet Financial information for Insulet Read the full ...

Represents 9th Consecutive Year of 20% or More Constant Currency 1 Revenue Growth; Annual Revenue Surpasses $2 Billion Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of ...

2025-02-20 14:40:23 ET More on Beta Bionics, Inc. Beta Bionics: A Sugar Rush For This IPO Beta Bionics Aims For IPO To Cover Heavy Losses Artificial pancreas maker Beta Bionics aims to raise $204M in Nasdaq IPO Beta Bionics sets terms for upsized $165M IPO ...

Airbus SE ADR - Level I (EADSY) is expected to report $0.66 for Q4 2024 Prelude Therapeutics Incorporated (PRLD) is expected to report $-0.49 for Q4 2024 Boise Cascade L.L.C. (BCC) is expected to report $1.82 for Q4 2024 CN Energy Group Inc. (CNEY) is expected to report for quarter en...

2025-02-19 03:20:00 ET Summary Q4 S&P 500 EPS growth expected to come in at 16.9%, the highest growth rate in three years. Large cap outlier earnings dates this week include: ANSYS, Akamai Technologies and Trimble Inc. The third week of peak season begins this week, with 1...

2025-02-16 09:20:54 ET More on Albemarle, Align Technology, etc. Intel Stock: Deep Manufacturing Analysis Signals Geopolitical Security Weekly Indicators: Confirming The 'Steady As She Goes' Economy AMD: The AI Contender With A Significant Correction, But It Isn't Ch...

2025-02-05 13:15:15 ET More on Abbott Laboratories, DexCom, etc. Abbott Laboratories: Strong Q4 Results And Bullish Outlook Abbott Laboratories: Now Back In The Buy Zone (Rating Upgrade) Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript X adds more c...

Shares of Insulet Corporation (NASDAQ: PODD) traded at a new 52-week high today and are currently trading at $285.14. So far today, approximately 114.87k shares have been exchanged, as compared to an average 30-day volume of 484.92k shares. Insulet Corporation develops, manufactures, and sell...